Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV) (vol 55, pg 7650, 2012)

被引:0
|
作者
Beaulieu, Pierre L.
Boes, Michael
Cordingley, Michael G.
Chabot, Catherine
Fazal, Gulrez
Garneau, Michel
Gillard, James R.
Jolicoeur, Eric
LaPlante, Steven
McKercher, Ginette
Poirier, Martin
Poupart, Marc-Andre
Tsantrizos, Youla S.
Duan, Jianmin
Kukolj, George
机构
关键词
D O I
10.1021/jm501225c
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:7144 / 7144
页数:1
相关论文
共 39 条
  • [31] SAFETY, TOLERABILITY AND ANTIVIRAL ACTIVITY OF MK-7009, A NOVEL INHIBITOR OF THE HEPATITIS C VIRUS NS3/4A PROTEASE, IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 INFECTION
    Lawitz, Eric J.
    Sulkowski, Mark S.
    Jacobson, Ira M.
    Faruqui, Shaban
    Kraft, Walter K.
    Maliakkal, Benedict
    Al-Ibrahim, Mohamed
    Ghalib, Reem H.
    Gordon, Stuart C.
    Kwo, Paul
    Rockstroh, Juergen
    Miller, Michelle
    Hwang, Peggy
    Gress, Jacqueline
    Quirk, Erin
    HEPATOLOGY, 2008, 48 (04) : 403A - 404A
  • [32] Phase 1 study assessing the safety, pharmacokinetics, and antiviral activity of CC-31244, a pan-genotypic, potent non-nucleoside NS5B polymerase inhibitor for the treatment of hepatitis C virus infection
    Lee, S.
    Pascual, L.
    Pattassery, J.
    Sulkowski, M.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S720 - S720
  • [33] From benzimidazole to indole-5-carboxamide Thumb Pocket I inhibitors of HCV NS5B polymerase. Part 1: Indole C-2 SAR and discovery of diamide derivatives with nanomolar potency in cell-based subgenomic replicons
    Beaulieu, Pierre L.
    Gillard, James
    Jolicoeur, Eric
    Duan, Jianmin
    Garneau, Michel
    Kukolj, George
    Poupart, Marc-Andre
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (12) : 3658 - 3663
  • [34] EVALUATION OF PHARMACOKINETIC DRUG-DRUG INTERACTION (DDI) BETWEEN BMS-791325, AN NS5B NON-NUCLEOTIDE POLYMERASE INHIBITOR, DACLATASVIR AND ASUNAPREVIR IN TRIPLE COMBINATION IN HCV GENOTYPE 1-INFECTED PATIENTS
    Wang, X.
    Li, W.
    Huang, S. -P.
    He, B.
    Chung, E.
    Griffies, A.
    Cooney, E.
    Hughes, E.
    Kandoussi, H.
    Sims, K.
    Gardiner, D.
    Bertz, R.
    Eley, T.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S184 - S184
  • [35] A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION
    Tatum, H.
    Thuluvath, P.
    Lawitz, E.
    Martorell, C. T.
    Demicco, M.
    Cohen, S.
    Rustgi, V.
    Ravendhran, N.
    Ghalib, R.
    Hanson, J.
    Zamparo, J.
    Yang, R.
    Hughes, E.
    Cooney, E.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S460 - S460
  • [36] SOUND-C2: SVR4, 12, and 24 concordance in genotype (GT) 1 HCV patients receiving interferon (IFN)-free treatment with the HCV NS3/4A protease inhibitor BI 201335 and the NS5B polymerase inhibitor BI 207127
    Zeuzem, Stefan
    Soriano, Vincent
    Asselah, Tarik
    Bronowicki, Jean-Pierre
    Lohse, Ansgar W.
    Mullhaupt, Beat
    Schuchmann, Marcus
    Bourliere, Marc
    Buti, Maria
    Roberts, Stuart K.
    Gone, Edward J.
    Stern, Jerry O.
    Vinisko, Richard
    Herichova, Ivona
    Boecher, Wulf O.
    Mensa, Federico J.
    HEPATOLOGY, 2012, 56 : 569A - 569A
  • [37] Discovery of N-[4-[6-tert-Butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a Potent Inhibitor of the Hepatitis C Virus NS5B Polymerase
    Talamas, Francisco X.
    Abbot, Sarah C.
    Anand, Shalini
    Brameld, Ken A.
    Carter, David S.
    Chen, Jun
    Davis, Dana
    de Vicente, Javier
    Fung, Amy D.
    Gong, Leyi
    Harris, Seth F.
    Inbar, Petra
    Labadie, Sharada S.
    Lee, Eun K.
    Lemoine, Remy
    Le Pogam, Sophie
    Leveque, Vincent
    Li, Jim
    McIntosh, Joel
    Najera, Isabel
    Park, Jaehyeon
    Railkar, Aruna
    Rajyaguru, Sonal
    Sangi, Michael
    Schoenfeld, Ryan C.
    Staben, Leanna R.
    Tan, Yunchou
    Taygerly, Joshua P.
    Villasenor, Armando G.
    Weller, Paul E.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (05) : 1914 - 1931
  • [38] Discovery of (7R)-14-Cyclohexyl-7-{[2-(dimethylamino)ethyl](methyl) amino}-7,8-dihydro-6H-indolo[1,2-e][1,5]benzoxazocine-11-carboxylic Acid (MK-3281), a Potent and Orally Bioavailable Finger-Loop Inhibitor of the Hepatitis C Virus NS5B Polymerase
    Narjes, Frank
    Crescenzi, Benedetta
    Ferrara, Marco
    Habermann, Jorg
    Colarusso, Stefania
    Ferreira, Maria del Rosario Rico
    Stansfield, Ian
    Mackay, Angela Claire
    Conte, Immacolata
    Ercolani, Caterina
    Zaramella, Simone
    Palumbi, Maria-Cecilia
    Meuleman, Philip
    Leroux-Roels, Geert
    Giuliano, Claudio
    Fiore, Fabrizio
    Di Marco, Stefania
    Baiocco, Paola
    Koch, Uwe
    Migliaccio, Giovanni
    Altamura, Sergio
    Laufer, Ralph
    De Francesco, Raffaele
    Rowley, Michael
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) : 289 - 301
  • [39] Discovery of 5-(3-((1, 3-difluoro-2-(fluoromethyl)propan-2-yl)carbamoyl)phenyl)-6-(N-(2-fluoroethyl)methylsulfonamido)-2-(4-fluorophenyl)-N-methylbenzofuran-3-carboxamide, the first orally bioavailable pan-genotype coverage HCV NS5B inhibitor with sulfonamide moiety at C-6 of benzofuran core
    Yin, Zhiwei
    Zhang, Zhongxing
    Wang, Tao
    Parcella, Kyle
    Eastman, Kyle
    Grant-Young, Katharine
    Yeung, Kap-Sun
    Wang, Ying-Kai
    Fang, Hua
    Lemm, Julie
    Zhuo, Xiaoliang
    Liu, Mengping
    Mosure, Kathy
    Krause, Rudolph
    Roberts, Susan
    Soars, Matt
    Kadow, John
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250